Author Archives : Birgit Rogell

Home  >>  Author : Birgit Rogell

Apogenix Granted Orphan Designation by the European Commission for Asunercept to Treat Myelodysplastic Syndromes

On Oktober 11, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Apogenix Granted Orphan Designation by the European Commission for Asunercept to Treat Myelodysplastic Syndromes

Orphan designations facilitate the development and authorization of medicines for rare diseases, as assessed by the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products  Heidelberg, Germany, October 05, 2017 – Apogenix AG, a biopharmaceutical company developing next-generation immuno-oncology therapeutics, announced today that its lead product candidate, asunercept (APG101), has…

PROGEN acquires EuroProxima’s research antibodies

On Oktober 9, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für PROGEN acquires EuroProxima’s research antibodies

PROGEN Biotechnik GmbH expands portfolio in the cell biology market Heidelberg, 05.10.2017 – PROGEN Biotechnik GmbH, established manufacturer of premium antibodies, has recently acquired the research antibody line of the Dutch company EuroProxima B.V., a global provider of immunobiological test systems. The deal encompasses about 190 products that supplement PROGEN’s…

Roche: Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams

On Oktober 3, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Roche: Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams

Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams The NAVIFY Tumor Board solution is a new, cloud-based software solution that fundamentally changes the way oncology care teams prepare for, conduct and document clinical treatment decisions for cancer patients It supports care team collaboration and…

DKFZ: Endowed chair at the German Cancer Research Centre commences work thanks to a one-million Euro donation from CTS EVENTIM

On Oktober 3, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für DKFZ: Endowed chair at the German Cancer Research Centre commences work thanks to a one-million Euro donation from CTS EVENTIM

The German Cancer Research Centre (Deutsches Krebsforschungszentrum, DKFZ) has created an endowed Chair in Chromatin Networks with the University of Heidelberg. Karsten Rippe, a biophysicist, will take up the Chair and will lead this department of the DKFZ. The new professorship is funded by CTS EVENTIM, one of the world’s…

DKFZ researcher is among the world’s best in radiology

On Oktober 3, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für DKFZ researcher is among the world’s best in radiology

Alexander Radbruch, a radiologist at the German Cancer Research Center (DKFZ) has been recognized by peer professionals to be among the 15 most influential persons worldwide in the category Radiology Research. Radbruch has become known internationally in recent years from his studies showing that gadolinium, a contrast agent used for…

Roche: Roche receives EU approval of TECENTRIQ® (atezolizumab) in a specific type of metastatic lung cancer and two types of metastatic bladder cancer

On September 24, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Roche: Roche receives EU approval of TECENTRIQ® (atezolizumab) in a specific type of metastatic lung cancer and two types of metastatic bladder cancer

TECENTRIQ provides a new treatment option for people with previously treated locally advanced or metastatic non-small cell cancer (NSCLC) TECENTRIQ is a new treatment option for people with metastatic urothelial carcinoma (mUC) who have been previously treated with a platinum-based chemotherapy and for people who are ineligible to receive cisplatin…

Roche: Roche receives EU approval of Gazyvaro for people with previously untreated advanced follicular lymphoma

On September 24, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Roche: Roche receives EU approval of Gazyvaro for people with previously untreated advanced follicular lymphoma

Approval is based on phase III GALLIUM study results, which showed superior progression-free survival for Gazyva/Gazyvaro compared to MabThera/Rituxan Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved Gazyvaro® (obinutuzumab) in combination with chemotherapy, followed by Gazyvaro maintenance in people achieving a response, as a…

Roche: Roche receives European approval for Actemra /RoActemra in giant cell arteritis

On September 24, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Roche: Roche receives European approval for Actemra /RoActemra in giant cell arteritis

Actemra/RoActemra is the first therapy approved for the treatment of giant cell arteritis (GCA) in Europe GCA can lead to blindness, aortic aneurysm or stroke if left untreated The approval was based on the outcome of the phase III GiACTA study Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that…

Merck: European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma

On September 24, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Merck: European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma

First approved immunotherapy for rare and aggressive skin cancer in the European Union, with initial launches planned in Germany and the UK Builds on Bavencio’s previous accelerated approvals in the US and recent approval in Switzerland Approval is based on data from the Javelin Merkel 200 study including durable tumor…

EMBL: Visualization of inflammasome formation in real life

On September 21, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für EMBL: Visualization of inflammasome formation in real life

Fish On Fire ASC specks (in red) initiate reactions that result in cell death. PHOTO: EMBL/Leptin Group While immune sensing mechanisms vary widely between animals, ASC specks – particles that play a key role in triggering inflammation – form in humans as well as zebrafish. In a study published in…